Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03504020 · ClinicalTrials.gov registry record · NA
ECG Belt for CRT Response
A NA study of Heart Failure, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 498
- Enrollment target
- 20
- Study locations
NCT03504020: Completed NA study of Heart Failure, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT03504020 is a NA study of Heart Failure that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 498 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03504020, a NA study of Heart Failure, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 498 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this clinical study is to compare ECG Belt Research System managed cardiac resynchronization therapy (CRT) patients and a control CRT group with respect to left ventricular (LV) remodeling.
Primary Outcome
Relative (%) change in LVESV from the baseline measurement to the 6 month measurement.
Conditions Studied
Interventions
- DEVICE ECG Belt Research System
Study Locations (20)
Florida
- University of Florida Health Shands Hospital - Gainesville
- Florida Hospital Cardiovascular Research Institute - Orlando
- BayCare Health System - Tampa
North Carolina
- Atrium Health's Carolina Medical Center - Charlotte
- Duke University Medical Center - Durham
- North Carolina Heart and Vascular - Raleigh
Connecticut
- Hartford Hospital - Hartford
- Yale School of Medicine - New Haven
Louisiana
- Cardiovascular Institute of the South - Houma
- Advanced Cardiovascular Specialists - Shreveport
Missouri
- Saint Lukes Hospital of Kansas City - Kansas City
- Washington University School of Medicine - St Louis
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Illinois
- NorthShore University Health System - Evanston
Iowa
- Iowa Heart Center - West Des Moines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 498 participants |
| Start Date | 2018-07-13 |
| Est. Completion | 2022-04-20 |
| Phase | NA |
What the finished NCT03504020 record still lists
NCT03504020 is an interventional study that assigns participants to a tested intervention. The registered 498 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which ECG Belt Research System is the first listed.
NCT03504020 names 20 study sites across 13 states, led by Florida, North Carolina, Connecticut.
Frequently Asked Questions
What is clinical trial NCT03504020 about?
NCT03504020 is a clinical study titled "ECG Belt for CRT Response". The purpose of this clinical study is to compare ECG Belt Research System managed cardiac resynchronization therapy (CRT) patients and a control CRT group with respect to left ventricular (LV) remodeling.
What is the current status of trial NCT03504020?
This trial is currently completed. It is a NA study. The enrollment target is 498 participants. The study started on 2018-07-13. Estimated completion is 2022-04-20.
What conditions does trial NCT03504020 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03504020?
The interventions under investigation include: ECG Belt Research System (DEVICE).
Who is sponsoring clinical trial NCT03504020?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03504020 being conducted?
This trial has 20 study locations across Connecticut, District of Columbia, Florida, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03504020's enrollment target sits among peer trials
498 106th of 397 higher than 292 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT06733480 · 499 participants · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
- NCT03175224 · 497 participants · Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- NCT05301816 · 497 participants · NA
PDN Post Market, Multicenter, Prospective, Global Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI